Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Aarts

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Heart (British Cardiac Society)|May 20, 2025
Effect of low-dose colchicine on pericoronary inflammation and coronary plaque composition in chronic coronary disease: a subanalysis of the LoDoCo2 trialAernoud T L Fiolet, Andrew Lin, Jacek Kwiecinski, et al.
Cerebrovascular Diseases Extra|November 6, 2023
Prognostic Value of Histopathological Thrombus Age in Large Vessel Occlusion-Related StrokeBart Van Gorsel, Michel J M Remmers, Louwerens D Vos, et al.
Thrombosis Research|September 30, 2025
Thrombectomy in high-risk pulmonary embolism - device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trialW J E Stenger, C A den Uil, W J R Rietdijk, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Heart (British Cardiac Society)|May 20, 2025
Effect of low-dose colchicine on pericoronary inflammation and coronary plaque composition in chronic coronary disease: a subanalysis of the LoDoCo2 trialAernoud T L Fiolet, Andrew Lin, Jacek Kwiecinski, et al.
Cerebrovascular Diseases Extra|November 6, 2023
Prognostic Value of Histopathological Thrombus Age in Large Vessel Occlusion-Related StrokeBart Van Gorsel, Michel J M Remmers, Louwerens D Vos, et al.
Thrombosis Research|September 30, 2025
Thrombectomy in high-risk pulmonary embolism - device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trialW J E Stenger, C A den Uil, W J R Rietdijk, et al.
Pageof 1